Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Auditor change
Appointed director
Director comp.
Acq. announced
BioCardia, Inc. (BCDA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "BIOCARDIA REPORTS SECOND QUARTER 2023 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS Sunnyvale, Calif. – August 9, 2023 - BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reports financial results for the second quarter of 2023 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2023 with the Securities and Exchange Commission. The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights. Following management’s formal remarks, there will be a question-and-answer session. “We have followed the recent recommendation from our Data Safety Monitoring Board to pause enrollment of new patients in our autologous cell ..."
05/10/2023 8-K Quarterly results
Docs: "BIOCARDIA REPORTS FIRST QUARTER 2023 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS Sunnyvale, Calif. – May 10, 2023 - BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reports financial results for the first quarter of 2023 and filed its quarterly report on Form 10-Q for the three months ended March 31, 2023 with the Securities and Exchange Commission. The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights. Following management’s formal remarks, there will be a question-and-answer session. “Our autologous and allogeneic cell therapy programs are advancing in the clinic, with three enabled by our Helix cardiac biotherapeutic delivery system..."
11/09/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/29/2022 8-K Quarterly results
Docs: "BIOCARDIA REPORTS 2021 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS Sunnyvale, Calif. – March 29, 2022 - BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2021 and filed its annual report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission. The Company will also hold an update conference call at 4:30 PM ET, in which it will discuss business highlights. Following management’s formal remarks, there will be a question and answer session. Participants can register for the conference by navigating to https://dpregister.com/sreg/10164538/f1ee9a93ce. Please note that registered participants w..."
11/10/2021 8-K Quarterly results
Docs: " "
05/13/2021 8-K Quarterly results
03/30/2021 8-K Quarterly results
08/13/2020 8-K Quarterly results
11/16/2004 8-K Quarterly results
Docs: "CONSOLIDATED STATEMENTS OF OPERATIONS"
11/14/2003 8-K Quarterly results
Docs: "Exhibits 3 Signatures 4 -2-"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy